Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

3.92USD
25 Jul 2017
Change (% chg)

$-0.06 (-1.51%)
Prev Close
$3.98
Open
$3.97
Day's High
$4.05
Day's Low
$3.91
Volume
32,499
Avg. Vol
65,452
52-wk High
$5.77
52-wk Low
$1.62

NYMX.OQ

Chart for NYMX.OQ

About

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the... (more)
No analyst recommendations are available for NYMX.OQ.

Overall

Beta: 0.84
Market Cap(Mil.): $192.53
Shares Outstanding(Mil.): 49.12
Dividend: --
Yield (%): --

Financials

  NYMX.OQ Industry Sector
P/E (TTM): -- 214.05 15.73
EPS (TTM): -0.27 -- --
ROI: -- -7.97 -8.37
ROE: -- -9.29 -7.93

Earnings vs. Estimates